Semaglutide is a GLP-1 receptor agonist , a medication that mimics the effects of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)
Other extra-intestinal tissues (e.g., liver, skeletal muscle, and skin) also synthesize glycine from 4-hydroxyproline (Hu et al
The typical starting dose is 0.25 mg, which is gradually increased to 1 mg over a few weeks to minimize side effects and enhance tolerance
Sainsbury K, Evans EH, Pedersen S, Marques MM, Teixeira PJ, Lhteenmki L, et al
Fecal microbiota transplantation in amyotrophic lateral sclerosis: clinical protocol and evaluation of microbiota immunity axis